There are some instances where single-gene or single syndrome testing may be preferred over a larger genetic testing panel. This is especially true when a patient’s diagnosis or family history is very suggestive for a certain syndrome or there is a known familial variant.
Single-site testing is available when there is a known variant in the family. This test is available for any of the 66 genes on our Comprehensive Hereditary Cancer Panel.
Test name |
Test code |
GSP or CPT coding |
FAQ |
Hereditary Cancer Single Site(s) |
Please call Genomic Client Services 1.866.GENE.INFO (1.866.436.3463) for more information |
We have added single-gene tests for specific instances when a patient’s personal and/or family history points to a specific gene instead of a broader evaluation.
Test name |
Test code |
GSP or CPT coding |
FAQ |
APC Sequencing and Deletion/Duplication |
81201, 81203 |
||
ATM Sequencing and Deletion/Duplication |
81408, 81479 |
||
BAP1 Sequencing and Deletion/Duplication |
81479 |
||
BLM Sequencing and Deletion/Duplication |
81479 |
||
CDH1 Sequencing and Deletion/Duplication |
81406, 81479 |
||
CDKN2A Sequencing and Deletion/Duplication |
81404, 81479 |
||
CHEK2 Sequencing and Deletion/Duplication |
81479 |
||
Lynch Syndrome, MSH2 Sequencing and Deletion/Duplication (Including EPCAM) |
81295, 81297, 81403 |
||
FH Gene Sequencing and Deletion/Duplication |
81405, 81479 |
||
FLCN Sequencing and Deletion/Duplication |
81479 |
||
HOXB13 Sequencing and Deletion/Duplication |
81479 |
||
MEN1 Sequencing and Deletion/Duplication |
81405, 81404 |
||
MITF Gene Analysis |
81479 |
||
Lynch Syndrome, MLH1 Sequencing and Deletion/Duplication |
81292, 81294 |
||
Lynch Syndrome, MSH6 Sequencing and Deletion/Duplication |
81298, 81300 |
||
MUTYH Sequencing and Deletion/Duplication |
81406, 81479 |
||
NF1 Sequencing and Deletion/Duplication |
81408, 81479 |
||
PALB2 Sequencing and Deletion/Duplication |
81307, 81479 |
||
Lynch Syndrome, PMS2 Sequencing and Deletion/Duplication |
81317, 81319 |
||
PTEN Sequencing and Deletion/Duplication |
81321, 81323 |
||
RET Sequencing and Deletion/Duplication |
81406, 81479 |
||
SMARCA4 Sequencing and Deletion/Duplication |
81479 |
||
STK11 Sequencing and Deletion/Duplication |
81405, 81404 |
||
Li-Fraumeni Syndrome, TP53 Sequencing and Deletion/Duplication |
81351, 81479 |
||
VHL Sequencing and Deletion/Duplication |
81404, 81403 |
Test codes may vary by location. Please contact your local laboratory for more information.
Components of panels may be ordered separately.
The CPT® codes provided are based on American Medical Association guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.
Only a patient’s treating physician can make diagnoses, prognostic or treatment decisions based on the knowledge of the patient, history and clinical/educational experience. Quest lab testing provides information for the physician to use in helping make such decisions.
Please talk to your Quest representative for ordering information on our comprehensive portfolio of hereditary cancer test offerings.
Hereditary cancer links
Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services. Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services.
Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.
